Validation of a pandemic-proof, decentralized cardiovascular trial: scalable design produces rapid recruitment, high engagement and protocol adherence in DeTAP (Decentralized Trial in Afib Patients)

28 August 2021 (20:15 - 20:24)
Organised by:
Congress Presentation Part of: COVID and digital health Trial Design ESC Premium Access ESC Congress 2021 - The Digital Experience